$Direxion Daily S&P Biotech Bu

$Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ Ever wonder why BD deals in China’s biotech scene have been booming lately? Simple the Fed’s hawkish stance is squeezing innovation in the US. Biotech firms over there are seriously struggling to survive, especially with heavy R&D costs. That’s why global pharma giants are turning to China. Lower costs, strong science，it’s a golden setup. And for plays like LABU, this could be a prime time to load up!

Winning Trades

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":424407003844992,"tweetId":"424407003844992","gmtCreate":1744622787213,"gmtModify":1744623456997,"author":{"id":3479274696871559,"idStr":"3479274696871559","authorId":3479274696871559,"authorIdStr":"3479274696871559","name":"qwertd","avatar":"https://static.tigerbbs.com/486f271ec3baea83584935933913eb15","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":93,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/e40abb58469743d3f3a816530b7ceb74","width":"767","height":"1280"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/e40abb58469743d3f3a816530b7ceb74","width":"767","height":"1280"}],"html":"<html><head></head><body> <a data-mention-id=\"LABU\" class=\"teditor-mention\" data-mention-name=\"Direxion Daily S&amp;P Biotech Bull 3x Shares\" href=\"https://ttm.financial/S/LABU\">$Direxion Daily S&amp;P Biotech Bull 3x Shares(LABU)$</a> Ever wonder why BD deals in China’s biotech scene have been booming lately? Simple the Fed’s hawkish stance is squeezing innovation in the US. Biotech firms over there are seriously struggling to survive, especially with heavy R&amp;D costs. That’s why global pharma giants are turning to China. Lower costs, strong science，it’s a golden setup. And for plays like LABU, this could be a prime time to load up!<img src=\"https://community-static.tradeup.com/news/e40abb58469743d3f3a816530b7ceb74\" tg-width=\"767\" tg-height=\"1280\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"LABU\" class=\"teditor-mention\" data-mention-name=\"Direxion Daily S&amp;P Biotech Bull 3x Shares\" href=\"https://ttm.financial/S/LABU\">$Direxion Daily S&amp;P Biotech Bull 3x Shares(LABU)$</a> Ever wonder why BD deals in China’s biotech scene have been booming lately? Simple the Fed’s hawkish stance is squeezing innovation in the US. Biotech firms over there are seriously struggling to survive, especially with heavy R&amp;D costs. That’s why global pharma giants are turning to China. Lower costs, strong science，it’s a golden setup. And for plays like LABU, this could be a prime time to load up!<img src=\"https://community-static.tradeup.com/news/e40abb58469743d3f3a816530b7ceb74\" tg-width=\"767\" tg-height=\"1280\"></body></html>","text":"$Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ Ever wonder why BD deals in China’s biotech scene have been booming lately? Simple the Fed’s hawkish stance is squeezing innovation in the US. Biotech firms over there are seriously struggling to survive, especially with heavy R&D costs. That’s why global pharma giants are turning to China. Lower costs, strong science，it’s a golden setup. And for plays like LABU, this could be a prime time to load up!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/424407003844992","repostId":0,"isVote":1,"tweetType":1,"viewCount":0,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["LABU"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":380,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/424407003844992"}